×
GreekEnglish

×
Monday
25
Nov 2024
weather symbol
Athens 7°C

> Pfizer CEO Albert Bourla

> Pfizer CEO Albert Bourla

Pharmaceutical industry spring summit: Greece at the heart of pharmaceutical innovation

The Prime Minister's meeting with the CEOs of the world's largest industries in the sector marks the beginning of a new era that will upgrade our country, attracting billions in investment. Huge potential for growth in biotechnology, pharmaceutical manufacturing, digital health, clinical trials and biopharmaceutical services for the benefit of the national economy and citizens

PM Kyriakos Mitsotakis meeting with the global pharmaceutical industry’s elite at Maximou

See photos - The 25 heads of the world's leading pharmaceutical companies from Europe, the United States and Japan are in Greece at the initiative of Pfizer Chairman and CEO Albert Bourla

Bilderberg Group meeting in Lisbon – Artificial intelligence will top the agenda

Pfizer CEO Bourla is on the list of the attendees

Pfizer to invest its profits from Covid-19 vaccines in cancer treatment

In 2021, Pfizer's revenue will reach approximately $80 billion, and in 2022, it will exceed $100 billion

U.S Senator demands answers from Pfizer CEO Bourla over video about alleged gain of function research

The 10-minute video shows an alleged Pfizer director talking about research involving 'mutations' of viruses

Pfizer CEO pulls out of testifying to EU Parliament COVID panel

High-level contacts between Albert Bourla and European Commission President Ursula von der Leyen before the multibillion-euro vaccine deal are under scrutiny

Pfizer CEO Albert Bourla gets Covid for a second time

He said he was feeling well

Pfizer CEO Bourla has Covid-19

He has received 4 doses of his company's vaccine

Mitsotakis: Pfizer’s investment in Thessaloniki is a historic moment for the country (video)

Inauguration of the Pfizer Digital Innovation Center

Pfizer CEO Albert Bourla says vaccine-resistant coronavirus variant would eventually emerge

Bourla added that Pfizer could produce new versions of its vaccine to combat a variant within three months of its discovery